Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Diagnostic e-script safe harbor?

This article was originally published in The Gray Sheet

Executive Summary

HHS Office of the Inspector General is requesting comments on whether a safe harbor under the federal anti-kickback statute for hospitals and insurance plans providing free equipment for writing electronic drug prescriptions should extend to e-prescription technologies used for medical tests and supplies, an Oct. 11 1proposed rule notes. The proposed rule establishes the drug e-prescription safe harbor, which was mandated by the Medicare Modernization Act to encourage adoption of electronic health records...

You may also be interested in...

HHS Finalizes Safe Harbors To Promote Health IT

New rules released Aug. 1 designed to encourage adoption of electronic prescribing provide a safe harbor for physicians to receive equipment for transmitting e-prescriptions for drugs, lab tests and durable medical equipment

P&G: Sales Growth Strongest When Rising Tide Floats All Competitors Across All Categories

P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.

COVID-19 Vaccine 'Brexit Bonus' A Myth

The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts